Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (101-110 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|March 26, 2009
[From a crisis to another...Pharmaceutical industry--economics]A J Scheen
Revue Medicale De Liege|March 1, 1994
[How I treat... a non-obese patient with Type 2 diabetes]A J Scheen
Acta Clinica Belgica|August 30, 2003
Prevention of cardiovascular disease: plea for a rationale use of diet and lipid-lowering drugsA J Scheen
Revue Medicale De Liege|June 15, 2007
[Glucagon-like peptide-1 (GLP-1), new target for the treatment of type 2 diabetes]A J Scheen
Acta Clinica Belgica|June 26, 2008
Medications in the kidneyA J Scheen
Revue Medicale De Liege|January 16, 2002
[Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study]A J Scheen
Revue Medicale De Liege|February 1, 2002
[Clinical study of the month. Toxicity of hyperglycemia in intensive care and beneficial effects of optimized insulin therapy]A J Scheen
Revue Medicale De Liege|September 18, 2002
[Prevention of type II diabetes by inhibiting the renin-angiotensin system]A J Scheen
Revue Medicale De Liege|February 5, 2003
[Therapeutic advances in 2002 (1)]A J Scheen
Revue Medicale De Liege|July 30, 2002
[Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs]A J Scheen
Pageof 79

Showing results (101-110 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|March 26, 2009
[From a crisis to another...Pharmaceutical industry--economics]A J Scheen
Revue Medicale De Liege|March 1, 1994
[How I treat... a non-obese patient with Type 2 diabetes]A J Scheen
Acta Clinica Belgica|August 30, 2003
Prevention of cardiovascular disease: plea for a rationale use of diet and lipid-lowering drugsA J Scheen
Revue Medicale De Liege|June 15, 2007
[Glucagon-like peptide-1 (GLP-1), new target for the treatment of type 2 diabetes]A J Scheen
Acta Clinica Belgica|June 26, 2008
Medications in the kidneyA J Scheen
Revue Medicale De Liege|January 16, 2002
[Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study]A J Scheen
Revue Medicale De Liege|February 1, 2002
[Clinical study of the month. Toxicity of hyperglycemia in intensive care and beneficial effects of optimized insulin therapy]A J Scheen
Revue Medicale De Liege|September 18, 2002
[Prevention of type II diabetes by inhibiting the renin-angiotensin system]A J Scheen
Revue Medicale De Liege|February 5, 2003
[Therapeutic advances in 2002 (1)]A J Scheen
Revue Medicale De Liege|July 30, 2002
[Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs]A J Scheen
Pageof 79